10.1097/00008571-200208000-00003-Reference-Cited by-同舟云学术

10.1097/00008571-200208000-00003

Published:2002-08-01 Issue:6 Volume:12 Page:429-436
ISSN:0960-314X
Container-title:Pharmacogenetics
language:
Short-container-title:Pharmacogenetics

Author:

Schwab Matthias,Schaffeler Elke,Marx Claudia,Fischer Christine,Lang Thomas,Behrens Christoph,Gregor Michael,Eichelbaum Michel,Zanger Ulrich,Kaskas Bernd

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Pharmacology, Toxicology and Pharmaceutics,Genetics

Reference51 articles.

1. Azathioprine: State of the Art in Inflammatory Bowel Disease

2. The treatment of inflammatory bowel disease with 6-mercaptopurine or azathioprine

3. Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease

4. 6-Mercaptopurine in the Management of Inflammatory Bowel Disease: Short- and Long-Term Toxicity

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Azathioprine-induced Pancytopenia Leading to Mucormycosis in a Patient - Case Report;2024-08-13

2. Predictive role of ITPA genetic variants in thiopurine-related myelotoxicity in Crohn’s disease patients;The Pharmacogenomics Journal;2024-06-21

3. Evaluation of tolerance to mercaptopurine in patients with inflammatory bowel disease and gastrointestinal intolerance to azathioprine;Gastroenterología y Hepatología (English Edition);2024-05

4. Immunosuppressant Medications in Pregnancy;Obstetrics & Gynecology;2024-01-16

5. Novel Management of Masticatory Myositis in Three Dogs with a Selective Janus Kinase (JAK-1) Inhibitor;Journal of Veterinary Dentistry;2024-01-08